Moderna (MRNA) Other Non-Current Assets (2017 - 2026)
Moderna's Other Non-Current Assets came in at $618 million for Q2 2026, up 13.2% from $546 million a year earlier but down 8.4% from the prior quarter.
Moderna (MRNA) Other Non-Current Assets (2017 - 2026) Analysis & Trends
At the end of FY2025, Moderna's Other Non-Current Assets was $605 million, up 1.9% from FY2024.
- Other Non-Current Assets carries a five-year compound annual growth rate of 122.9% (FY2020 to FY2025).
- Going back by year, Other Non-Current Assets was $594 million in FY2024 (-22.5%), $766 million in FY2023 (-22.5%), $988 million in FY2022 and $46 million in FY2021 (+318.2%).
- The five-year range for quarterly Other Non-Current Assets is $11 million (Q3 2021) to $1.29 billion (Q2 2023).
- Year-over-year, Other Non-Current Assets has increased for three consecutive quarters, with an average decline of 4.5% over the last eight quarters.
- The fastest year-over-year change in Other Non-Current Assets over five years came in Q1 2022 (growth of 645.5%), and the weakest in Q2 2024 (a decline of 50.3%).
- Business Quant data shows MRNA's Other Non-Current Assets at $675 million (Q1 2026), $605 million (Q4 2025) and $530 million (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | 7.70 Bn |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 15.10 Bn |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | 9.42 Bn |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 19.90 Bn |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | 700.00 Mn |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | - |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | 14.60 Bn |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | 4.90 Bn |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 10.02 Bn |
| 10 | Moderna | 100.92 Bn | 80.27 Bn | 52.00 Mn | 618.00 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 618.00 Mn |
| Mar 31, 2026 | 675.00 Mn |
| Dec 31, 2025 | 605.00 Mn |
| Sep 30, 2025 | 530.00 Mn |
| Jun 30, 2025 | 546.00 Mn |
| Mar 31, 2025 | 556.00 Mn |
| Dec 31, 2024 | 594.00 Mn |
| Sep 30, 2024 | 556.00 Mn |
| Jun 30, 2024 | 641.00 Mn |
| Mar 31, 2024 | 650.00 Mn |
| Dec 31, 2023 | 766.00 Mn |
| Sep 30, 2023 | 661.00 Mn |
| Jun 30, 2023 | 1.29 Bn |
| Mar 31, 2023 | 1.16 Bn |
| Dec 31, 2022 | 988.00 Mn |
| Sep 30, 2022 | 52.00 Mn |
| Jun 30, 2022 | 87.00 Mn |
| Mar 31, 2022 | 94.00 Mn |
| Dec 31, 2021 | 46.00 Mn |
| Sep 30, 2021 | 11.00 Mn |
Moderna Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=MRNA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "MRNA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=MRNA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();